Franklin Resources’s Epizyme, Inc EPZM Stock Holding History

Franklin Resources’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-960,200	Closed	-$17M	–	1553
2018 Q1	$17M	Hold	960,200	–	–	0.01%	819
2017 Q4	$12.1M	Sell	960,200 -74,900	-7%	-$1.09M	0.01%	901
2017 Q3	$19.7M	Hold	1,035,100	–	–	0.01%	796
2017 Q2	$15.6M	Sell	1,035,100 -127,900	-11%	-$1.93M	0.01%	856
2017 Q1	$19.9M	Hold	1,163,000	–	–	0.01%	783
2016 Q4	$14.1M	Sell	1,163,000 -37,000	-3%	-$386K	0.01%	875
2016 Q3	$11.8M	Hold	1,200,000	–	–	0.01%	937
2016 Q2	$12.3M	Hold	1,200,000	–	–	0.01%	925
2016 Q1	$14.5M	Buy	+1,200,000	New	+$12.1M	0.01%	880
2013 Q4	–	Sell	-350,000	Closed	-$14M	–	1535
2013 Q3	$14M	Sell	350,000 -4,100	-1%	-$139K	0.01%	890
2013 Q2	$9.96M	Buy	+354,100	New	+$9.1M	0.01%	940

Other funds holding EPZM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Franklin Resources's EPZM Position: Q2 2018 in Review

Franklin Resources sold out of Epizyme, Inc (EPZM) in Q2 2018, closing a stake of 960,200 shares — an estimated $17M sold.

Franklin Resources first reported a position in EPZM in Q2 2013 and held it in 11 quarters. The position peaked at $19.9M in Q1 2017. 109 funds tracked by Wall St. Rank hold EPZM as of Q2 2018.

Franklin Resources reported no remaining Epizyme, Inc position as of Q2 2018 after selling out during the quarter.
Franklin Resources sold 960,200 Epizyme, Inc shares in Q2 2018, an estimated $17M.
Franklin Resources first reported a position in Epizyme, Inc in Q2 2013 and held it in 11 quarters.
Franklin Resources's Epizyme, Inc position peaked at $19.9M in Q1 2017.
109 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2018.

Based on Franklin Resources's 13F filing for Q2 2018, filed 14 Aug 2018.